PacBio Appoints Mark Van Oene as President and Chief Executive Officer
August 5, 2026
Christian Henry to Transition from President and Chief Executive Officer Following Six Years of Leadership; Effective August 5, 2026 MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions, today announced that its Board of Directors has appointed Mark Van Oene as President and [...]
August 5, 2026
OBERKOCHEN, Germany -- Revolune today announced a partnership with Propath UK to expand customer access to Revolune's multiplex immunofluorescence workflow. Under the partnership, Propath UK will join Revolune's Service Provider Program, supporting customers who want to access Revolune-powered multiplex staining workflows through an experienced service laboratory. The partnership is designed to help researchers and translational [...]
AnalytiChem launches CONOSTAN® GC standards range for fuel testing
August 4, 2026
New CONOSTAN ASTM D3606 method standards range covers the complete GC analysis workflow AnalytiChem’s new CONOSTAN® ASTM D3606 standards range ensures complete confidence in benzene and toluene content testing in fuels by GC. Eschborn, Germany -- AnalytiChem, manufacturer of specialized chemicals, reagents, accredited standards, equipment and consumables, has introduced a new range of CONOSTAN® Gas Chromatography [...]
August 4, 2026
FLASH program, in collaboration with GE HealthCare, to support development of faster, distributed DNA manufacturing for next-generation therapies Paris, France -- DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced that in collaboration with prime awardee GE HealthCare, they have been awarded up to $26 million [...]
August 4, 2026
The phenol-free magnetic bead workflow includes DNase treatment to optimize cfRNA recovery for downstream sequencing and amplification IPSWICH, Mass. -- New England Biolabs (NEB®) announces the release of the Monarch Mag Cell-free RNA (cfRNA) Extraction Kit, which enables isolation of low-abundance, circulating cell-free RNA (cfRNA) and exome-associated RNA from biofluids including plasma, serum, urine and [...]
August 4, 2026
BOSTON and ROLLE, Switzerland -- SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS's decentralized clinical trial assays and companion [...]
August 4, 2026
New offerings deliver a full biochemome as a $200-per-sample full-service readout or a $25-per-sample subscription/enterprise license to run on a laboratory's own instruments SOMERVILLE, Mass. -- PyxisLabs™, Matterworks, Inc.'s AI Native Laboratory for scalable biochemical omics and predictive biology, today announces two commercial offerings: biochemical analysis services and enterprise subscription licenses for quantitative, untargeted biochemical [...]
August 4, 2026
A transatlantic partnership gives biotech startups lower-cost access to lab equipment while reducing waste and Scope 3 emissions through circular sourcing. "Biotech startups are under pressure to do more with less in the current funding environment, and procurement is one of the fastest ways to extend the runway.” — Matej Metkovic ALAMEDA, CA, UNITED STATES -- [...]
Danaher Appoints Julie Sawyer Montgomery as President and Chief Executive Officer
August 3, 2026
Rainer Blair to retire WASHINGTON -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a [...]
August 3, 2026
WALTHAM, Mass. Key Facts Thermo Scientific™ X2 and S2 Series General Purpose Centrifuges enable labs to improve sustainability without compromising performance. X2 and S2 Centrifuges deliver high performance in a smaller, more versatile format for medical research, biopharma and clinical labs. Additional benefits: Improved sustainability through a low-GWP natural refrigerant system and more energy efficiency [...]

